Low catalytic efficiency of protein kinases often results from intrasteric inhibition caused by the activation loop blocking the active site. In the insulin receptor's kinase domain, Asp-1161 and Tyr-1162 in the peptide substrate-like sequence of the unphosphorylated activation loop can interact with four invariant residues in the active site: Lys-1085, Asp-1132, Arg-1136, and Gln-1208. Contributions of these six residues to intrasteric inhibition were tested by mutagenesis, and the unphosphorylated kinase domains were characterized. The mutations Q1208S, K1085N, and Y1162F each relieved intrasteric inhibition, increasing catalytic efficiency but without changing the rate-limiting step of the reaction. The mutants R1136Q and D1132N were virtually inactive. Steric accessibility of the active site was ranked by relative changes in iodide quenching of intrinsic fluorescence, and A-loop conformation was ranked by limited tryptic cleavage. Together these ranked the openness of the active site cleft as R1136Q Ϸ D1132N > D1161A > Y1162F Ϸ K1085N > Q1208S > wildtype. These findings demonstrate the importance of specific invariant residues for intrasteric inhibition and show that diverse activation loop conformations can produce similar steady-state kinetic properties. This suggests a broader range of regulatory properties for the activation loop than expected from a simple offversus-on switch for kinase activation.
Intrasteric inhibition is a regulatory feature used by many protein kinases to suppress catalytic activity (1) (2) (3) (4) . This form of inhibition is achieved when a polypeptide segment of the kinase blocks or distorts the active site, thereby preventing binding or proper orientation of one or both substrates. One frequently observed structural feature of intrasteric inhibition is a "pseudosubstrate" amino acid sequence that has the consensus recognition sequence of a true peptide substrate but does not always have the phosphoryl acceptor hydroxy-amino acid. A pseudosubstrate sequence is not a universal feature of intrasteric inhibition, as in the case of calcium/calmodulin-dependent protein kinase I in which distortion, more than occlusion, of the active site occurs (5) .
Catalytic activity of the insulin receptor's kinase domain (IRKD 1, 2 ) is suppressed through intrasteric inhibition by an activation loop (A-loop), which has a pseudosubstrate sequence between Asp-1161 and Lys-1165. The intrasterically inhibitory "gate-closed" conformation identified in a crystal structure of the unphosphorylated kinase domain (7) blocks both ATP and peptide substrate binding sites, as shown schematically in Fig.  1 (see below). The side chains of Phe-1151 to Met-1153 that block the adenine binding pocket probably do not contribute to stability of the gate-closed conformation, as suggested by high B values for the Phe-1151 ring and the undefined side chain of Met-1153. In contrast, binding of the pseudosubstrate sequence appears to be stable, as inferred from the lower B values of the pseudosubstrate side chains and the potential to form numerous hydrogen bonds (7) . Taken together these observations suggest that intrasteric inhibition at both ATP and peptide binding sites would be determined by interactions at the peptide binding site.
Among residues shown in Fig. 1 that are potentially involved in stabilizing pseudosubstrate binding, six are invariant within the insulin receptor family. 3 Three of the six hydrogen bonding residues are invariant in the tyrosine kinase superfamily (Asp-1132 and Arg-1136 in the catalytic loop, and the presence of one tyrosyl residue, either Tyr-1162 or Tyr-1163, in the A-loop), and three are variable in the tyrosine kinase superfamily (Lys-1085, Asp-1161, and Gln-1208; see Table I below). The latter residues are engaged in a triad of interactions in the basal state of the IR (see Fig. 1 ), which may be absent in other tyrosine kinases due to amino acid differences in at least one of these residues (see Table I , boldface letters). Importantly, the homologous residues of closely related tyrosine kinases such as the fibroblast growth factor receptor and Src family kinases do not appear to interact with each other in crystal structures in which the A-loops are unphosphorylated, and these A-loops do not show pseudosubstrate binding nor do they block the ATP binding site (8 -12) . Therefore, the residues participating in these interactions in the insulin receptor's kinase domain may be necessary for maintenance of the gate-closed conformation and intrasteric inhibition.
To evaluate contributions of each residue to the gate-closed conformation, we made a set of single amino acid replacements to disrupt the hydrogen bonds shown in Fig. 1 . A D1161A mutation has been reported, showing that loss of three interactions (1, 2, and 3, Fig. 1 ) produced an unphosphorylated kinase with increased catalytic efficiency (13, 14) . The structure of this mutant IRKD displayed a "gate-open" conformation in which the ATP binding site was freed and pseudosubstrate binding of the A-loop was not observed; most residues in the A-loop were disordered. With this background information and the other mutants in hand, we tested the following three hypotheses: First, if each residue making up the bonding network in Fig. 1 is required to maintain intrasteric inhibition, then mutation of any one residue should yield a gate-open conformation and loss of intrasteric inhibition. Second, if intrasteric inhibition at the ATP binding site depends on interactions at the peptide binding site, then mutating residues at the peptide binding site will lower K m, ATP . Third, if a specific function of A-loop autophosphorylation is to lower the K m, peptide , then a gate-open conformation in these unphosphorylated kinase mutants will not improve K m, peptide . The steady-state kinetic results presented here suggest intrasteric inhibition of the insulin receptor requires each of these invariant residues. However, physical and biochemical evidence indicate that a range of A-loop conformations accompanies the changes in kinetic parameters.
EXPERIMENTAL PROCEDURES
Materials-Dithiothreitol (Sigma Ultra grade), the disodium salt of ATP (from equine muscle, catalog number A-5394), ADP, and bovine serum albumin (BSA) were purchased from Sigma Chemical Co.; hydrogenated Triton X-100 (protein grade) was from Calbiochem; EDTA was from Fluka; Tris acetate, Tris base, Tris-HCl, the ATP analogs adenosine 5Ј-(␤,␥-imido)triphosphate (AMP-PNP, tetralithium salt), and electrophoresis reagents were from Roche Molecular Biochemicals; magnesium acetate (MgAc 2 , Enzyme Grade) was from Fisher. Insect cell culture media and fetal bovine serum were from Life Technologies, Inc.
Synthetic Peptides and Nucleotides-The synthetic peptide IRS939 with a single phosphorylation site was prepared as the carboxyl-terminal amide. The amino acid sequence, REETGSEYMNMDLG, is taken from the residues surrounding Tyr-939 of rat insulin receptor substrate-1 (GenBank TM accession number X58375). Preparation of stock solutions of the peptide and adenine nucleotides was described previously (15) .
Subcloning, Protein Expression, and Purification of IRKD MutantsBaculovirus encoding amino acid residues 953-1355 of the insulin receptor's cytoplasmic kinase domain was provided by the late Dr. Ora Rosen (16) . The mutants were subcloned in this laboratory using a human insulin receptor cDNA provided originally by Dr. Jonathan Whittaker (17) .
The following mutations were made in the IRKD: Asp-1132 was changed to Asn or Gly and Arg-1136 was changed to Gln; each mutation causes loss of the charged group of the side chain. A Tyr-1162 mutation to Phe is a standard change in a phosphorylation site for the insulin receptor (cf., Refs. 18 -20) and removes the OH group and its ability to hydrogen bond with Arg-1136 or Asp-1132. The mutation Lys-1085 to Asn was based on the TRK sequence, and mutation of Gln-1208 to Ser was based on fibroblast growth factor receptor (Table I) . Taken from closely related receptor tyrosine kinases, each substitution might have the least impact on the mutant's ability to catalyze phosphoryl transfer, in contrast to the R1136Q and D1132N mutations. Overlap-extension polymerase chain reactions (OE-PCR) were used to generate these IRKD mutants with pairs of oligonucleotides as "inner primers" encoding the mutation and pairs of oligonucleotides as "outer primers" to generate a fragment for endonuclease digestion and subcloning (21, 22) . Specific nucleotide sequences of the primers and the exact subcloning protocols will be provided by the corresponding author upon request. The template vector for OE-PCR was pXCKD (22) . The pXCKD was used for subcloning cDNAs to yield 48-kDa kinases encoding residues 953-1355 with Met preceding Arg-953, and a plasmid pX⌬⌬CKD was used to encode double-truncation mutants yielding 36-kDa proteins, including residues 978 -1283, and a Met preceding Val-978 (21) . Most OE-PCR products were digested with BstXI and StuI and inserted into pXCKD or pX⌬⌬CKD at the unique BstXI and StuI sites. The D1132N-IRKD (48-and 36-kDa forms) mutation was subcloned with added silent mutations to add a new ApaLI restriction site. Subcloning the K1085N-IRKD (36 kDa) added a silent mutation for a new BglII restriction site. Subcloning the Y1162F-IRKD (36 kDa) introduced a silent mutation for a new SmaI site. Subcloning the Q1208S-IRKD (36 kDa) mutant encoded a silent mutation that nullified an EcoNI restriction site. The cDNA inserts encoding each mutant IRKD were subcloned into the baculovirus expression vector pVL1392 or pVL1393, and the recombinant viruses were generated using the BaculoGold kit from PharMingen.
Wild-type and mutant kinase domains were expressed in "High Five" cells (Invitrogen), maintained at 27.5 Ϯ 0.5°C. The monolayers were grown to 60% confluence at the time of infection. Each viral infection was done for 3-4 h at a multiplicity of infection of 10. The infection media was then replaced with fresh media. Cells were harvested at 48 -54 h from the start of infection. Cells were resuspended in homogenization buffer (250 mM sucrose, 50 mM Tris base, 20 mM NaCl at pH 7.5), and stored at Ϫ80°C, at least overnight. IRKD purification was done as described in Bishop et al. (23) , with modifications to accommodate charge changes resulting from the double-truncation and point mutations (e.g. the mutation converting Asp-1132 to Gly). The first anion-exchange chromatography step for purification of the 36-kDa kinases used a 50-ml SOURCE 15Q matrix (Amersham Pharmacia Asp-1161 at the P Ϫ1 site, Tyr-1162 at P 0 , Tyr-1162 at P ϩ1 , and Lys-1165 at P ϩ3 (not shown). Hydrogen bonds between two of these A-loop residues and four residues from the catalytic core are indicated by the dashed lines, numbered 1 to 5. There are hydrogen bonds between the side chains of Gln-1208 and Lys-1085 (number 6) and between Asp-1132 and Arg-1136 (number 7). These features of intrasteric inhibition were described originally by Hubbard (7) in a crystal structure of the unphosphorylated wild-type kinase domain of the human insulin receptor. 
a HIR, human insulin receptor. b IR, insulin receptor; IGF1R, insulin-like growth factor-1 receptor; IRR, insulin receptor-related receptor; FGFR, fibroblast growth factor receptor; TRK, neurotrophin receptor; LTK, leukocyte tyrosine kinase; 7LESS, sevenless receptor of Drosophila melanogaster; AX1, growth arrest-specific gene 6 receptor; MET, hepatocyte growth factor receptor.
Biotech) rather than a Waters DEAE 8HR matrix. Other steps in the purification scheme were essentially the same as for the 48-kDa kinases.
Iodide Quenching of Fluorescence-Steady-state and time-resolved fluorescence measurements were made as described by Bishop et al (23) . Briefly, the emission spectra were obtained with an SLM 4800 spectrofluorometer operating in the single-photon counting mode. For intrinsic tryptophan fluorescence spectra, an excitation wavelength of 300 nm was used and emission spectra were collected over the range of 310 -420 nm in 1-nm increments. The final spectra were determined from the average of three spectral scans. Iodide quenching was done in the absence or presence of ADP as described by Ablooglu and Kohanski (15) . The IRKD was 1 M, and quenching was done with 0.0 -0.6 M KI in 50 mM TrisAc, 20 mM MgAc 2 , and 0.1 mM sodium thiosulfate, at pH 7.0; the potassium salt concentration was kept constant at 0.6 M by the addition of KCl, as needed. For each IRKD, the bimolecular collisional rate constant k q was determined as described previously (15, 23) .
Limited Tryptic Cleavage-Partial proteolysis of the IRKD was done according to Frankel et al. (21) . Briefly, the IRKD was digested at 5 M in cleavage buffer (50 mM TrisAc, 20 mM MgAc 2 , 1 mM DTT, 2 mM CaCl 2 , pH 7.0) with or without 10 mM ADP. Trypsin was added to a ratio of 1:20 by mass, trypsin to IRKD. The reaction proceeded for selected times and was quenched by addition of sample buffer. The cleavage products were resolved by SDS-polyacrylamide gel electrophoresis. Gels were stained with AgNO 3 and dried, scanned as grayscale images using an Arcus II scanner (Agfa) with Fotolook and Photoshop software (Adobe), and quantified using ImageQuaNT software (Molecular Dynamics, Sunnyvale CA).
Steady-state Kinetics and Viscosity Dependence of Peptide Substrate Phosphorylation-Steady-state kinetic parameters for the unphosphorylated kinase domains were determined as described previously (15) . Reactions were performed, in triplicate, at room temperature with 50 nM mutant or wild-type IRKD in 50 mM TrisAc, 5 mM DTT, 0.05% BSA (w/v), with one substrate at a fixed concentration and the second substrate concentration varied. In all reactions, product formation was no greater than 10% of the limiting substrate, and autophosphorylation of the IRKDs did not occur during these measurements. The kinetic parameters were determined from a fit of the initial velocity versus variable substrate concentration using the hyperbolic form of the MichaelisMenten equation. Data with the dead-end inhibitor AMP-PNP were analyzed assuming simple linear competitive inhibition against ATP, using a concentration range of 0.1 to 5 mM AMP-PNP (and no inhibitor in the control reactions), 0.2-2 mM ATP, and fixed 1 mM IRS939. The viscosity dependence for k cat and k cat /K m, peptide were determined using sucrose as the microviscogen, following procedures described previously (15) ; control experiments ruling out potential artifacts arising in viscosity dependence experiments are described in that study.
To determine K m, peptide for the activated kinases, each mutant IRKD was autophosphorylated for 30 -60 min at a concentration of 2 M kinase, 5 mM ATP, 10 mM MgAc 2 , 0.01% hydrogenated Triton X-100, 5 mM DTT, 50 mM TrisAc, pH 7.0, which produced maximum activation of each kinase (not shown). The activated kinase was diluted into peptide phosphorylation reaction mixtures to give a final concentration of 2-4 nM; dephosphorylation does not occur after dilution (i.e. during the assay). Peptide phosphorylation was assayed at 0.025-2 mM IRS939, at fixed 10 mM MgATP.
RESULTS

Relief of Intrasteric Inhibition Revealed through Steady-state
Kinetics-Low catalytic efficiency is the functional hallmark of intrasteric inhibition of the unphosphorylated IRKD. It is produced by low k cat and high K m for both substrates (15) . The steady-state kinetic parameters for three mutants are summarized in Table II , together with previously published control data for the WT-IRKD and D1161A-IRKD. These results show relief of intrasteric inhibition for Q1208S-, K1085N-, and Y1162F-IRKD, based on increased catalytic efficiencies (k cat / K m ). There were 4-to 6-fold increases in k cat and 12-to 22-fold decreases in K m, MgATP compared with the WT-IRKD, but K m, peptide was essentially unchanged in each of these mutant IRKDs. These features were observed previously in the D1161A-IRKD mutant (Table II) , suggesting that a mutation breaking any subset of hydrogen bonds for pseudosubstrate recognition relieves intrasteric inhibition.
The Michaelis constant is often equated with a dissociation constant, although this does not apply in all kinetic mechanisms. Therefore, to determine if a lower K m, MgATP represents an increased affinity for adenine nucleotide, we measured the inhibition constant for AMP-PNP, which is an analog of ATP that does not support phosphoryl transfer. Surprisingly, the K i, AMP-PNP indicated slightly stronger nucleotide binding to the Q1208S-IRKD but 5-to 7-fold tighter nucleotide binding for the K1085N-and Y1162F-IRKD mutants. This result subdivides these kinase mutants in two groups, in which intrasteric inhibition is accompanied by (a) tighter nucleotide binding (K1085N-, Y1162F-, and D1161A-IRKD) or (b) occurs with only a modest change in affinity (Q1208S-IRKD).
The residues Lys-1085 and Gln-1208 interact with the P Ϫ1 residue of the peptide substrate, 4 shown in structures of the activated IRKD (24, 25) . Mutation of these residues could affect directly the value of K m, peptide . This was tested in the activated (autophosphorylated) forms of the mutant kinases (Table III) . The value for K m, peptide for the activated Q1208S-IRKD was equivalent to activated WT-IRKD, but the K m, peptide for activated K1085N-IRKD was 5-fold higher. The data show that Lys-1085 is more important than Gln-1208 for K m, peptide . This result suggests the substitution of Ser for Gln-1208 does not disrupt pseudosubstrate binding of the A-loop as much as substitution of Asn for Lys-1085. The surprising result was the relatively high K m, peptide for autophosphorylated Y1162F-IRKD compared with the other autophosphorylated kinases. This probably resulted from a limiting stoichiometry of 1 mol of phosphate per mol of IRKD after autophosphorylation (not shown), and at least two phosphotyrosines are required for significant activation (26) . The autophosphorylation of Q1208S-and K1085N-IRKD was equivalent to WT-IRKD (ϳ3 mol of phosphate per mol of 36 kDa IRKD; not shown).
The R1136Q-and D1132N-IRKD mutants were effectively inactive. Attempts to measure peptide phosphorylation indicated k cat was decreased by a factor of at least 10 3 for each mutant compared with WT-IRKD. The reduced k cat for these mutants is similar to values determined for other protein kinases with mutations in the homologous residues (27) (28) (29) (30) . Because of these low turnover numbers, we made no attempt to determine K m, MgATP or K m, peptide for these two mutants.
Rate-limiting Steps in the Mutant IRKDs-Previous studies showed that relief of intrasteric inhibition was accompanied by changes in the rate-limiting step of the catalytic cycle, without (14) or with (15) activation loop phosphorylation. We probed these unphosphorylated mutant IRKDs for similar changes by measuring k cat and k cat /K m, peptide at increasing solution viscosity. As shown in Fig. 2 , neither parameter differed from the unphosphorylated WT-IRKD for any of the three mutants examined here, unlike the D1161A-IRKD. Therefore, the phosphoryl transfer reaction remains limited by a viscosity-insensitive step despite the relief of intrasteric inhibition from steady-state kinetics for the K1085N-, Y1162F-, and Q1208S- The A-loop tyrosine mutant Y1162F-IRKD showed iodide quenching of fluorescence in the absence of ADP that was similar to the WT-IRKD⅐ADP binary complex (Fig. 3A) . There was virtually no change in iodide quenching measured in the presence of ADP. These results suggest this Tyr-to-Phe mutant adopts a gate-open conformation. Similarly, iodide quenching of fluorescence in D1132N-IRKD, with or without nucleotide, was similar to the WT-IRKD⅐ADP binary complex (Fig. 3B) . A slightly different result was observed for the R1136Q-IRKD mutant; iodide quenching was significantly greater than WT-IRKD in the absence of ADP but did not appear to be as extensive as the two previously analyzed mutants. Nevertheless, the quenching was not affected significantly when ADP was present, which suggests a gate-open conformation has arisen in this mutant. Iodide quenching of fluorescence in the K1085N-IRKD was greater than the WT-IRKD, and it was increased slightly when ADP was bound (Fig. 3C) . This mutant also can be considered gate-open. Within this cohort of mutants, iodide quenching of fluorescence in Q1208S-IRKD in the absence of ADP was most like quenching of the WT-IRKD in the absence of ADP (Fig. 3D) . In addition, quenching in the presence of ADP was essentially the same for the Q1208S mutant and the WT-IRKD. These results suggest a mostly gate-closed conformation for Q1208S-IRKD, consistent with the weak affinity for adenine nucleotides described above by K i, AMP-PNP (Table II) . Given the difference in iodide quenching due to bound ADP, we were able to titrate the equilibrium binding of adenine nucleotides to Q1208S-IRKD by the method described in Ablooglu and Kohanski (15) (titrations not shown). The dissociation constants were 2.0 Ϯ 0.3 mM AMP-PNP and To make full use of the quenching data from steady-state fluorescence, we used fluorescence lifetimes to calculate bimolecular collisional rate constants for iodide quenching. This provides a good index of changes in solute exposure due to the mutations and/or nucleotide binding, and relative solute exposure is an indication of a gate-closed versus gate-open conformation (23) . The intensity-weighted mean fluorescence lifetimes were determined from time-resolved fluorescence decay analysis of each mutant in the absence and presence of saturating ADP (Fig. 4A) . One pattern is immediately apparent: the lifetime decreases in WT-IRKD and in every mutant IRKD upon ADP binding, except for the R1136Q-IRKD. This could indicate a change in conformation or local electronic environment near the fluorescent tryptophanyl residues of the IRKD with bound nucleotide. A more subtle pattern can be discerned in which the WT-IRKD and Q1208S have similar decay lifetimes in their unliganded states, with an average value for ͗͘ of 7.43 Ϯ 0.25 ns, compared with the four gate-open mutants with an average value for ͗͘ of 6.36 Ϯ 0.18 ns.
The bimolecular collisional rate constants are arranged to suggest a gradient of increasing solute access between the gate-closed WT-IRKD and the gate-open D1132N-IRKD ( Fig.  4B; open bars) . The Q1208S-IRKD is more similar to the WT-IRKD than to other mutant IRKDs, with the Q1208S-IRKD appearing partially gate-open by this comparison. Quenching increased 9.3-fold upon nucleotide binding to the WT-IRKD and 3.4-fold for the Q1208S-IRKD, with the difference due mostly to the increased k q for Q1208S-IRKD in the absence of bound nucleotide. In contrast, the -fold increase in k q is only 1.3 Ϯ 0.1 for the gate-open mutants upon ADP binding (except for R1136Q-IRKD, for which the change in k q upon nucleotide binding is opposite to all the other IRKDs examined). These data demonstrate a range of IRKD conformations based on solute accessibility and reveal that bound nucleotide does have a further impact on the conformation of the kinase domain, in the gate-closed WT-IRKD and the gate-open mutant proteins.
Limited Proteolysis and Activation Loop ConformationTrypsin cleaves the A-loop of the WT-IRKD, and the relative rate of cleavage is increased by bound adenine nucleotide (Ref. 21 and Fig. 5, lanes 1-3) . Limited proteolysis of the mutant IRKDs, for a fixed time, provides a survey of A-loop conformations in the absence versus the presence of ADP (Fig. 5, lanes  3-18) . Compared with WT-IRKD, in which A-loop cleavage was barely detectable, there was greater A-loop cleavage in the absence of ADP in each of the mutants, including the Q1208S mutant, although the difference was small in that case. The extent of cleavage appeared greatly enhanced when ADP was bound to the WT-and Q1208S-IRKDs, modestly increased for the K1085N-and Y1162F-IRKDs, and barely changed for the R1136Q-and D1132N-IRKDs, where cleavage was already extensive in the absence of nucleotide (Fig. 5 , summarized in the last panel).
Quantitative analysis of A-loop cleavage over time is shown in the semi-logarithmic plots to better illustrate differences in cleavage rates among IRKDs and the effects of ADP (Fig. 6) . The WT-IRKD and Q1208S-IRKD cleave very slowly in the absence of ADP, reaching barely 20% net cleavage by 20 min (Fig. 6A) . In the presence of ADP, the WT-IRKD shows two approximately linear phases of cleavage, which suggests two conformational populations exist in the binary complex (each conformation is cleaved at a different rate). Similar results are obtained with the Q1208S-IRKD (Fig. 6A) . Extrapolation of the slow phases to zero time indicates about 50 -60% of the cleavage occurs via this slow phase; i.e. there is an ϳ50 -50 split between two A-loop conformations in each of these binary complexes.
Cleavage of the A-loop in the K1085N-and Y1162F-IRKDs in the absence of ADP is faster than for the WT-IRKD (Fig. 6B ). There is a slight increase in the rate of cleavage in each IRKD when ADP is bound. This finding confirms a conformational change in these binary complexes compared with IRKDs without bound nucleotide, as suggested by the fluorescence data. There appears to be one predominant A-loop conformation under each condition for both mutants, although slight curvature in these plots suggests a lower abundance second conformation could be present. The A-loop conformations in the K1085N-and Y1162F-IRKD are quite similar to each other, with or without nucleotide, and both differ from conformations apparent in the WT-and Q1208S-IRKDs.
Limited proteolysis of the A-loop in the R1136Q-and D1132N-IRKD mutants is very fast and affected only slightly by the presence of ADP (Fig. 6C) . The single phase of cleavage appears to report a single A-loop conformation for each mutant in the absence or presence of ADP (Fig. 6C) . Therefore, taking the iodide quenching and limited proteolysis data together, it appears that both of the catalytically inactive IRKD mutants have gate-open conformations in the absence of bound nucleotide, and the A-loop conformation is different in the presence versus the absence of nucleotide. ") . B, the bimolecular collisional rate constants were determined for iodide quenching, based on the relationship k q ϭ K sv /͗͘, using values for ͗͘ from A and the data shown in Fig. 2 . Error bars show one standard deviation. rylated activation loop is the intrasteric inhibitor of its kinase activity (7), shown schematically in Fig. 1 . This gate-closed conformation produces low catalytic efficiency against both substrates, as defined by k cat /K m, MgATP and k cat /K m, peptide (15) .
In this report, we studied the relationship between the structural and functional components of intrasteric inhibition using point mutations in the IRKD. Conclusions were reached for the three hypotheses stated in the introduction: First, each residue making up the hydrogen bond network in Fig. 1 is required to maintain intrasteric inhibition, based on the increased catalytic efficiency from each mutant. However, the structural component can be retained while the kinetic component of intrasteric inhibition is released, as shown by the gate-closed conformation in the Q1208S-IRKD that has increased catalytic efficiency. Second, intrasteric inhibition at the ATP binding site depends on interactions at the peptide binding site. This is supported by the change in K m, MgATP produced by mutations affecting substrate/pseudosubstrate recognition and the correlation between K i, AMP-PNP and gate-closed versus gate-open conformations. Third, a specific function of A-loop autophosphorylation is to lower the K m, peptide . This appears to be true because none of the gate-open mutants had a lower K m, peptide than the WT-IRKD prior to autophosphorylation. In addition to addressing these hypotheses, the results demonstrate that a high K m, peptide does not require filling of the peptide binding site by the pseudosubstrate sequence, because K m, peptide remained high after the gate-closed conformation was lost. Furthermore, we show that multiple activation loop conformations can have similar steady-state kinetic features. These findings are summarized in Table IV .
The kinetic component of intrasteric inhibition requires each of the interactions shown in Fig. 1 . This conclusion is based on the finding that catalytic efficiency was increased when any subset of interactions was broken, provided that residues in the catalytic loop, Arg-1136 and Asp-1132, were left intact. We measured increases in k cat /K m of 50-to 130-fold for MgATP and 3-to 7-fold for peptide substrate (Table II) . These shared kinetic changes resulted from the 8 Ϯ 3-fold-increased k cat and 12 Ϯ 3-fold-lower K m, MgATP , although the K m, peptide showed an average 1. The K1085N-, Y1152F-, and D1161A-IRKD mutants share an increased affinity for adenine nucleotide, but they can be subdivided further using the patterns of viscosity dependence for steady-sate kinetic parameters (Fig. 2) . The parameter k cat is given by the expression,
where k 3 is the rate constant for the chemical step of phosphoryl transfer and k 4Ј is the net rate constant for product release, including conformational changes required to allow product dissociation (33) . The viscosity dependence will reveal if k cat is limited by the chemical step of the reaction (k 3 Ͻ k 4Ј ) or net product release steps (k 4Ј Ͻ k 3 ), if the slope in a plot such as shown in Fig. 2A is 0 or 1, respectively (see Ref. 34 for details, and Ref. 15 for specific details related to the steady-state kinetic mechanism of WT-IRKD). For the mutants K1085N-and Y1162F-IRKD, the slope was ϳ0, and therefore, k cat Ϸ k 3 , indicating that k 3 is rate-limiting. In contrast, for D1161A-IRKD the slope was ϳ0.8 and thus k 3 Ͼ k 4Ј , and k 3 is partially rate-limiting (14) . In this respect, D1161A-IRKD is different from the other mutants and the WT-IRKD. The average value of k 3 is 5.8 s Ϫ1 for K1085N-and Y1162F-IRKD, but k 3 is 59 s
Ϫ1
for D1161A-IRKD (14) . Compared with k 3 of 1.2 s Ϫ1 for the WT-IRKD (15), these results show that relief of intrasteric inhibition produced similar increases in k cat for each mutant (Table II) , and that increase reflects an increased value of k 3. However, the increase in k 3 is another order-of-magnitude greater for D1161A-IRKD than the other mutants. Furthermore, if one relied exclusively on the change in k cat from steadystate kinetics, this would not report the change in rate-limiting step that distinguishes the D1161A mutant; that change is revealed by the viscosity-dependence for k cat .
The catalytic efficiency reported by k cat /K m, peptide is increased 5-fold above the WT-IRKD for all four active mutants Table II ). Again, there is an underlying mechanistic difference for D1161A-IRKD that is revealed by the viscosity dependence studies (Fig. 2B) . The slope of zero indicates that peptide substrate equilibrates before the chemical transfer step in the reaction catalyzed by the K1085N-, Q1208S-, and Y1162F-IRKD mutants, as it does for the WT-IRKD; thus K m, peptide Ϸ K d, peptide . Therefore, the K1085N, Q1208S, and Y1162F mutants have weak peptide binding, similar to the WT-IRKD basal state (Table IV) . In contrast, the slope was ϳ1 for D1161A-IRKD, which indicates that peptide substrate does not equilibrate with D1161A-IRKD prior to the chemical step (14) , and K d, peptide is not determined for the D1161A mutant from these experiments. However, the data in Table III indicated that Lys-1085 makes a greater contribution to K m, peptide than does Gln-1208. This difference may explain the apparent gate-closed conformation displayed by the Q1208S mutant and the apparent gate-open conformation resulting from the K1085N mutation, as discussed below.
Participation of the A-loop in steric blockade of the active site was examined by changes in iodide quenching. The trend in bimolecular collisional rate constants shown in Fig. 4B best illustrates the "gradient" of conformations that occur among the unphosphorylated wild-type and mutant IRKDs (k q in the absence of adenine nucleotide; open bars). The larger values of k q can be interpreted as indicating greater accessibility of the active site, suggesting the order D1132N Ͼ D1161A Ն Y1162F Ͼ K1085N Ͼ Q1208S Ͼ WT for relative openness of the cleft. In contrast to these mutant IRKDs, interpreting changes in fluorescence properties of the R1136Q-IRKD mutant is difficult, because the mutation affects directly the fluorescence of Trp-1175, the major fluorophore in IRKD (23) . This effect is shown clearly by the lower mean fluorescence lifetime of R1136Q-IRKD (Fig. 4A) , which is probably caused by the loss of an interaction between the guanidinium group of Arg-1136 and the indole ring of Trp-1175, which has been seen in all IRKD crystal structures (7, 14, 24, 25) . In every other IRKD, bound adenine nucleotide appears to have an impact of conformation, because k q always increases in each binary complex compared with the apo-protein. Cleft openness is based on two factors: relative orientation of the small and large lobes and position of the activation loop.
We addressed changes in A-loop conformation through limited proteolysis of the A-loop. We also measured the impact of bound adenine nucleotide, because this promotes a gate-open conformation in the WT-IRKD (Ref. 21 and Fig. 5) , and because the binary complex differs from the unliganded IRKD according to the changes in fluorescence just described. These results yield the final grouping of IRKDs: the WT-and Q1208S-IRKD are mostly gate-closed in the absence of nucleotide, but at saturating nucleotide there are two nearly equal populations of A-loop conformations (Table IV) . This is suggested by the biphasic progress curves of A-loop cleavage shown in the semi- Fig. 1 . b Intrasteric inhibition based on relative k cat /K m from data in Table II , and gate conformation was inferred from Fig. 3 . c Affinities for AMP-PNP based on K i and for the peptide substrate IRS939 from K m in Table II . K m was used here by comparison with WT-IRKD, because there was no change in rate-limiting step for these kinases (Fig. 2) .
d One or two conformational populations, with numbers in brackets giving the ratios estimated from Fig. 6 . e ND, not determined.
logarithmic plots of Fig. 6A , where each phase represents one cleavage rate and one underlying conformation. 5 The K1085N-and Y1162F-IRKD are gate-open mutants, each showing one major conformational population, with a second population accounting for no more than 20 -30% of A-loop conformations (Table IV) . This interpretation applies in the absence or presence of ADP (Fig. 6B) . The D1132N-and R1136Q-IRKDs are gate-open, and single A-loop conformations are sufficient to account for each cleavage rate in the absence or presence of bound nucleotide; D1161A-IRKD falls into this category as well (Table IV) . The A-loop was disordered in the D1161A-IRKD structure (14) , which could indicate disorder in solution. However, in other protein kinase structural studies, it has been suggested that the appearance of disorder comes from the limited extent of data refinement (cf. Refs. 10 versus 9) or perhaps from crystallization conditions (e.g. Refs. 12 versus 11). Our results indicate that multiple A-loop conformations occur among these IRKDs in solution. Importantly, different conformations occur without modification of the A-loop amino acid sequence (e.g. K1085N and D1132N versus WT).
To summarize the changes produced by these point mutants in the functional components of intrasteric inhibition, all the active mutants share increased catalytic efficiency and weak peptide binding. In terms of how the catalytic cycle proceeds, the D1161A-IRKD is unique: K1085N-, Q1208S-, and Y1162F-IRKD are generally similar to WT-IRKD despite the increased catalytic efficiency of the mutants. The structural component of intrasteric inhibition is based on a gate-closed versus gate-open conformation. All the gate-open mutants have increased affinities for the adenine nucleotide AMP-PNP. The WT-and Q1208S-IRKD are gate-closed, but closure is weaker in the Q1208S mutant. Therefore, the hydrogen bond interactions 1 and 6 in Fig. 1 contribute least to the gate-closed conformation of the A-loop. It may be a general feature of the structural component of intrasteric inhibition that the A-loops become disordered when the gate-closed conformation is lost. In ERK2, Thr-183 and Tyr-185 have functions analogous to Tyr-1162 and Tyr-1163 of the IR, because their phosphorylation is essential for activation (35) . In crystallographic analysis of A-loop (T-lip) mutations in ERK2, it was demonstrated that mutation of Tyr-185 in the A-loop released it from a gate-closed conformation leading to loop disorder (36) . In contrast to Tyr-185 (which is buried (37)), mutation of the more-exposed Thr-183 did not release the gate-closed conformation and did not produce loop disorder, thereby demonstrating that key regulatory residues can be of greatly different importance in the basal versus the activated state. Through our solution studies we also have shown the relative importance of specific A-loop residues in maintaining a gate-closed conformation. Each of the mutations, other than Q1208S, breaks a subset of interactions required for the gate-closed conformation, as shown in Fig. 1, and The findings presented here, together with previous studies, may shed light on functions of A-loop conformations. First, a gate-closed conformation can be compatible with relatively high catalytic efficiency. Although low efficiency and a gateclosed conformation appear together in other protein kinases (e.g. Refs. 37, 38), it should not be surprising to find instances where they do not coincide. Second, weak peptide binding and A-loop mobility are compatible, suggesting that a fixed A-loop conformation based on pseudosubstrate recognition is not required to explain weak peptide binding. Indeed, because residues from the A-loop may contribute to the P ϩ1 and P ϩ3 binding pockets for residues in the peptide substrate (24, 39) 4 a mobile A-loop by itself should decrease the binding affinity for peptide substrate. Finally, shared steady-state kinetic parameters for different forms of an enzyme do not predict a shared conformation. Together these observations indicate that intrasteric inhibition in the IRKD is more subtle than off-versus-on regulation, and the inhibitory properties of mobile and rigid activation loops are both significant in the regulation of protein kinase activity.
